These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35976035)

  • 41. Impact of "a" determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B.
    Huang X; Ma C; Zhang Q; Shi Q; Huang T; Liu C; Li J; Hollinger FB
    J Med Virol; 2017 Oct; 89(10):1796-1803. PubMed ID: 28513915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers.
    Zhou S; Li T; Allain JP; Zhou B; Zhang Y; Zhong M; Fu Y; Li C
    J Med Virol; 2017 Dec; 89(12):2130-2137. PubMed ID: 28543299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
    Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
    J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal, South Africa.
    Msomi N; Ndlovu K; Giandhari J; Wilkinson E; Parboosing R; Zungu S; Mlisana K
    J Med Virol; 2019 Oct; 91(10):1797-1803. PubMed ID: 31180137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay.
    Kuhns MC; Holzmayer V; McNamara AL; Sickinger E; Schultess J; Cloherty GA
    J Clin Virol; 2019 Sep; 118():41-45. PubMed ID: 31442662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions.
    Hung WL; Wu JF; Ni YH; Chen HL; Chiang CL; Chang MH; Hsu HY
    Liver Int; 2019 Jun; 39(6):1052-1061. PubMed ID: 30790411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.
    Martin CM; Welge JA; Rouster SD; Shata MT; Sherman KE; Blackard JT
    J Viral Hepat; 2012 Oct; 19(10):716-23. PubMed ID: 22967103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
    Chen J; Liu Y; Zhao J; Xu Z; Chen R; Si L; Lu S; Li X; Wang S; Zhang K; Li J; Han J; Xu D
    PLoS One; 2016; 11(5):e0155654. PubMed ID: 27182775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China.
    Ye X; Li T; Shao W; Zeng J; Hong W; Lu L; Zhu W; Li C; Li T
    BMC Infect Dis; 2019 Jul; 19(1):574. PubMed ID: 31269905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.
    Powell EA; Boyce CL; Gededzha MP; Selabe SG; Mphahlele MJ; Blackard JT
    J Gen Virol; 2016 Jul; 97(7):1615-1624. PubMed ID: 27031988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
    Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
    J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection.
    El Chaar M; Candotti D; Crowther RA; Allain JP
    Hepatology; 2010 Nov; 52(5):1600-10. PubMed ID: 20815025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study.
    Taffon S; Genovese D; Blasi M; Pierotti P; Degli Esposti A; Catone S; Chionne P; Pulimanti B; Candido A; Dettori S; Tosti ME; Argentini C; Mazzotta F; Rapicetta M
    Infection; 2014 Aug; 42(4):675-87. PubMed ID: 24700252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and functional characterization of miR-451a as a novel plasma-based biomarker for occult hepatitis B virus infection.
    Hao Q; Wang Q; Qian H; Jiang J; Liu X; Xia W
    Microb Pathog; 2021 Dec; 161(Pt A):105233. PubMed ID: 34626767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.
    Foaud H; Maklad S; Mahmoud F; El-Karaksy H
    Infection; 2015 Jun; 43(3):307-14. PubMed ID: 25665956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.